Mode
Text Size
Log in / Sign up
N/A N=10 Single-blind Treatment

Dermatosis Papulosa Nigra

Facial Dermatoses · Seborrheic Keratoses

Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2014
Primary outcome: Primary: Percent Clearance of All Lesions — 88; 96; 92.5; 0 percentage of lesion clearance

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Pulsed dye laser (Device); Curettage (Procedure); Electrodesiccation (Procedure); No treatment (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, Davis
Primary completion
Dec 2009

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent Clearance of All Lesions
88; 96; 92.5; 0

Summary

DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).

Eligibility Criteria

Inclusion Criteria

  • Over 18 years of age.
  • Able to give informed consent.
  • Desires removal of lesions.
  • Willing to come back for six week follow-up.
  • Willing to fill out post operative questionnaire.
  • At least 4 lesions less than 7 mm.
  • Diagnosis of Dermatosis Papulosa Nigra (DPN)

Exclusion Criteria

  • Less than 18 years of age.
  • Pregnant.
  • Sensitive to laser energy.
  • History of Collagen Vascular Disorders.
  • History of Keloids.
  • History of post inflammatory hyperpigmentation.
  • Incarcerated.
  • Unable to give informed consent.
  • Unable to follow up for post operative evaluation.
  • Unable to complete patient visual analogue scale.
  • Unable to understand consent process or risks.
  • Unable to accept risk of scar, infection, minor bleeding, permanent or prolonged hyperpigmentation and hypopigmentation.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00710203). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search